Moleculin Biotech MBRX
NASDAQ MBRX
$0.53 -0.04 (-7.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Notes Payables (2015 - 2017)

Updated

Moleculin Biotech (MBRX) reported Notes Payables of $108,000 for Q1 2017, down 82.4% from $615,000 a year earlier and down 63.5% from the prior quarter.

Analysis

Moleculin Biotech (MBRX) Notes Payables (2015 - 2017) Analysis & Trends

At the end of FY2016, Moleculin Biotech posted Notes Payables of $296,000, down 34.2% from FY2015.

  • By year, Notes Payables came in at $450,000 in FY2015.
  • Per Business Quant data, the three quarters before Q1 2017 came in at $296,000 (Q4 2016), $297,656 (Q3 2016) and $431,644 (Q2 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Moleculin Biotech 3.24 Mn 3.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 108,000.00
Dec 31, 2016 296,000.00
Sep 30, 2016 297,656.00
Jun 30, 2016 431,644.00
Mar 31, 2016 615,000.00
Dec 31, 2015 450,000.00
API Access

Moleculin Biotech Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MBRX&period=max&api_key=YOUR_API_KEY